Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

China NMPA grants conditional approval to pamiparib for advanced ovarian cancer

May 7, 2021

Phase II trial shows improved PFS when relacorilant is added to nab-paclitaxel in ovarian cancer

May 7, 2021

Betta Pharmaceuticals synthesizes EGFR inhibitors

May 7, 2021

IMPACT Therapeutics identifies new Wee1 inhibitors

May 7, 2021

DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative

May 7, 2021

Aucentra Therapeutics patents CDK inhibitors

May 7, 2021

Medshine Discovery divulges new CDK inhibitors

May 7, 2021

Erasca opens enrollment in phase Ib/II study of ERAS-007 in advanced or metastatic solid tumors

May 7, 2021

Targeting RRM2 and mutant p53 as novel therapeutic strategy in TNBC

May 6, 2021

European Commission approves Xtandi for metastatic hormone-sensitive prostate cancer

May 6, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...